Abstract Background Oritavancin. a long-acting lipoglycopeptide approved for use in acute bacterial skin and skin structure infections. has limited data evaluating use in serious infections due to Gram-positive organisms. We aimed to assess the effectiveness and safety of oritavancin for consolidative treatment of Gram-positive bloodstream infections (BSI). https://threadheaders.shop/product-category/hat/